Dozens of Swedish doctors, scientists criticize country's coronavirus approach in grim op-ed

Sweden's unique approach to the coronavirus pandemic has drawn a lot of scrutiny from the rest of the world after the country chose to forego the harsh lockdowns enacted by many of its European peers. But now several of the country's own doctors and scientists are speaking out against the strategy in an op-ed published Tuesday by USA Today.
The experts warned other nations not to follow the Nordic country's footsteps. "At the moment, we have set an example for the rest of the world on how not to deal with a deadly infectious disease," the piece reads.
The evidence seems to back up the signees' grim outlook — Sweden has a per capita death toll greater than the United States, as well as a raw death toll that is 4.5 times greater than the other four Nordic countries (Iceland, Denmark, Finland, and Norway) combined, the op-ed notes. And the country's fatality rate has also been gaining on Italy, the first European country to be hit hard by COVID-19.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The signees expressed optimism about new medical treatments and vaccines, but until then, they said, don't do things "the Swedish way."
The same day as the op-ed, a report from the research firm Capital Economics suggested Sweden did weather the economic storm brought on by the virus better than its European counterparts and said the forecasted 1.5 percent drop in GDP this year "is well above consensus." However, the report also noted that Sweden was simply "the best of a bad bunch." Read the full op-ed at USA Today, as well as more about Sweden's economic situation at Business Insider.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Tim is a staff writer at The Week and has contributed to Bedford and Bowery and The New York Transatlantic. He is a graduate of Occidental College and NYU's journalism school. Tim enjoys writing about baseball, Europe, and extinct megafauna. He lives in New York City.
-
Business booms 'bigly' for Trump impersonators
Under The Radar 'Insane' demand for presidential doppelgangers at parties, golf tournaments – even children's birthdays
By Chas Newkey-Burden, The Week UK Published
-
When the insurer says ‘no’
Feature Health insurance companies appear to be denying a growing share of patient claims. Why?
By The Week US Published
-
Foreign aid: The human toll of drastic cuts
Feature The assault has 'stunned' nonprofits whose efforts to fight hunger, disease, and instability are now shuttering
By The Week US Published
-
Texas outbreak brings 1st US measles death since 2015
Speed read The outbreak is concentrated in a 'close-knit, undervaccinated' Mennonite community in rural Gaines County
By Rafi Schwartz, The Week US Published
-
Mystery illness spreading in Congo rapidly kills dozens
Speed Read The World Health Organization said 53 people have died in an outbreak that originated in a village where three children ate a bat carcass
By Peter Weber, The Week US Published
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
By Peter Weber, The Week US Published
-
New form of H5N1 bird flu found in US dairy cows
Speed Read This new form of bird flu is different from the version that spread through herds in the last year
By Peter Weber, The Week US Published
-
Microplastics accumulating in human brains, study finds
Speed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
By Peter Weber, The Week US Published
-
FDA approves painkiller said to thwart addiction
Speed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
By Rafi Schwartz, The Week US Published
-
Study finds possible alternative abortion pill
Speed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
By Peter Weber, The Week US Published
-
HMPV is spreading in China but there's no need to worry
The Explainer Respiratory illness is common in winter
By Devika Rao, The Week US Published